CareDx announced that CareDx and study collaborators will be presenting the latest data featuring CareDx’s cardiothoracic portfolio at the International Society for Heart and Lung Transplantation, ISHLT, 44th Annual Meeting & Scientific Sessions, taking place from April 10-13 in Prague, Czech Republic. “We are proud to have a leading presence once again at this pivotal heart and lung transplant meeting. We are especially pleased to share new results from our SHORE registry validating the clinical utility of surveillance using HeartCare testing,” said Alex Johnson, President of Patient and Testing Services, and member of the Office of the CEO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx Enhances Board with Financial Expert Riggsbee
- CareDx turns positive with CMS transplant update seen as positive
- CMS announcement positive for CareDx and Natera, says Craig-Hallum
- CMS says transplant patients can continue to access blood tests
- CareDx Unveils Updated Financial Health and Strategy Presentation
